Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Ovarian Stimulation in DUOSTIM Cycles
NCT05815719Phase 4Completed
- Sponsor
- Instituto Bernabeu
- Start
- Nov 2022
- Primary completion
- Apr 2023
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, open-label trial of corifollitropin alfa in infertility (2 arms), sponsored by Instituto Bernabeu. Primary endpoints: Total Number of Retrieved Oocytes at 4 weeks and Number of MII Oocytes at 4 months. Started Nov 2022; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05815719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05815719.